- Home
- ICON vs TRIB Comparison
ICON vs TRIB Comparison
Compare ICON & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- TRIB
- Stock Information
- Founded
- ICON 2023
- TRIB 1992
- Country
- ICON Greece
- TRIB Ireland
- Employees
- ICON N/A
- TRIB N/A
- Industry
- ICON
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ICON
- TRIB Health Care
- Exchange
- ICON Nasdaq
- TRIB Nasdaq
- Market Cap
- ICON 4.7M
- TRIB 5.4M
- IPO Year
- ICON 2024
- TRIB N/A
- Fundamental
- Price
- ICON $2.07
- TRIB $1.09
- Analyst Decision
- ICON Strong Buy
- TRIB
- Analyst Count
- ICON 1
- TRIB 0
- Target Price
- ICON $4.50
- TRIB N/A
- AVG Volume (30 Days)
- ICON 34.3K
- TRIB 101.5K
- Earning Date
- ICON 09-10-2025
- TRIB 11-14-2025
- Dividend Yield
- ICON 454.11%
- TRIB N/A
- EPS Growth
- ICON N/A
- TRIB N/A
- EPS
- ICON N/A
- TRIB N/A
- Revenue
- ICON $6,137,000.00
- TRIB $61,555,000.00
- Revenue This Year
- ICON $94.05
- TRIB $13.51
- Revenue Next Year
- ICON $18.81
- TRIB $13.14
- P/E Ratio
- ICON N/A
- TRIB N/A
- Revenue Growth
- ICON 25.60
- TRIB 8.31
- 52 Week Low
- ICON $1.60
- TRIB $0.48
- 52 Week High
- ICON $130.80
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- ICON 44.28
- TRIB 44.39
- Support Level
- ICON $2.00
- TRIB $1.00
- Resistance Level
- ICON $2.11
- TRIB $1.17
- Average True Range (ATR)
- ICON 0.10
- TRIB 0.07
- MACD
- ICON -0.00
- TRIB -0.00
- Stochastic Oscillator
- ICON 14.71
- TRIB 30.48
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.